New England Peptide Revenue and Competitors
Estimated Revenue & Valuation
- New England Peptide's estimated annual revenue is currently $3.6M per year.
- New England Peptide's estimated revenue per employee is $77,500
- New England Peptide's total funding is $7M.
Employee Data
- New England Peptide has 46 Employees.
- New England Peptide grew their employee count by -30% last year.
New England Peptide's People
| Name | Title | Email/Phone |
|---|
New England Peptide Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is New England Peptide?
New England Peptide offers a broad range of peptide and antibody products and services for research and development purposes. Headquartered in Gardner, MA, with significant operations in Louisville, KY, the company specializes in custom peptide synthesis services and the manufacturing and distribution of catalog peptides and biochemicals. Under the New England Peptide and Peptides International brands, the company also provides labeled bioanalytical peptide standards, enzyme substrates and inhibitors. From its two sites in North America, the company has the capacity and capabilities to service academia and pharmaceutical, biotech, and diagnostic companies worldwide. Additional information about New England Peptide is available at www.newenglandpeptide.com and www.pepnet.com.
keywords:N/A
$7M
Total Funding
46
Number of Employees
$3.6M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
New England Peptide News
New England Peptide; Biomatik; Proimmune. The profiling depicts different data along with item contributions, creation concentration, and key...
New Jersey, United States The Peptide Synthesis Market research report ... 21st Century Bio, CPC Scientific, LifeTein, AnaSpec, New England Peptide,...
Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript, AnaSpec, New England Peptide,...
New England Peptide, a Gardner, MA-based provider of custom peptides and antibodies to the global life sciences market, received a majority recapitalization from Ampersand Capital Partners. The amount of the deal was not disclosed. As part of the transaction, Dr. José de Chastonay joined as Exe ...
Other Companies in Gardner
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.9M | 46 | 0% | N/A |
#2 | $11.3M | 60 | 5% | N/A |
#3 | $20M | 95 | 4% | N/A |
#4 | $7.5M | 101 | 5% | N/A |
#5 | $18.6M | 120 | 28% | N/A |